• 1421 Citations
  • 20 h-Index
19992019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Antonello Domenico Cabras is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Mesothelioma Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

  • 1421 Citations
  • 20 h-Index
  • 57 Article
  • 2 Letter
Staphylococcal Protein A
Immunoglobulin M
Lymphoma
Waldenstrom Macroglobulinemia
Mutation
p16 Genes
Mesothelioma
Gene Deletion
Fluorescence In Situ Hybridization
Monosomy

HHV-8- and EBV-positive germinotropic lymphoproliferative disorder

Zanelli, M., Fraternali Orcioni, G., Zizzo, M., De Marco, L., Martino, G., Cerrone, G., Cabras, A. D. & Ascani, S., Oct 1 2019, In : Annals of Hematology. 98, 10, p. 2439-2441 3 p.

Research output: Contribution to journalLetter

PD-L1, LAG3, and HLA-DR are increasingly expressed during smoldering myeloma progression

Mussetti, A., Pellegrinelli, A., Cieri, N., Garzone, G., Dominoni, F., Cabras, A. & Montefusco, V., Jul 1 2019, In : Annals of Hematology. 98, 7, p. 1713-1720 8 p.

Research output: Contribution to journalArticle

HLA-DR Antigens
Multiple Myeloma
Plasma Cells
Cellular Microenvironment
Plasma Cell Neoplasms

Multicystic mesothelioma: Operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy

Nizri, E., Baratti, D., Guaglio, M., Sinukumar, S., Cabras, A., Kusamura, S. & Deraco, M., Jul 2018, In : European Journal of Surgical Oncology. 44, 7, p. 1100-1104 5 p.

Research output: Contribution to journalArticle

Mesothelioma
Drug Therapy
Carcinoma
Recurrence
Survival